Flaask, LLC

United States of America

Back to Profile

1-10 of 10 for Flaask, LLC Sort by
Query
Aggregations
IP Type
        Patent 9
        Trademark 1
Jurisdiction
        United States 6
        World 4
Date
2025 (YTD) 1
2024 2
2022 2
2021 1
2020 2
See more
IPC Class
A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA] 7
A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir 6
A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes 6
A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree 6
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives 5
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 1
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 1
Status
Pending 4
Registered / In Force 6

1.

Compositions and Methods for Diagnosing Susceptibility to Autism Spectrum Disorder (ASD), Reducing the Likelihood of Developing ASD, and/or Treating ASD

      
Application Number 18958836
Status Pending
Filing Date 2024-11-25
First Publication Date 2025-03-13
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew R.
  • Farmer, Sean
  • Alibek, Ken

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/175 - Amino acids
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 36/35 - Caprifoliaceae (Honeysuckle family)
  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
  • A61P 25/00 - Drugs for disorders of the nervous system

2.

QUALIFAM

      
Serial Number 98821224
Status Pending
Filing Date 2024-10-25
Owner FLAASK, LLC ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Dietary supplements; probiotic supplements; dietary supplemental drinks; dietary supplements in the forms of bars, gummies, capsules, tablets, gels and powders. Medical diagnostic services and provision of medical diagnostic information in the field of neurodegenerative diseases, neurodevelopmental disorders, infectious diseases, autoimmune diseases, allergies, genetics and gastrointestinal health; autism assessment and evaluation services, namely, assessment and evaluation for autism, autism risk factors and autism symptoms in patients and their family members; Health and medical consultation services for improving symptoms and quality of life for patients with autism; Health and medical consultation services for improving quality of life for families of patients with autism; nutrition consultation services.

3.

MATERIALS AND METHODS FOR REDUCING THE OCCURRENCE AND/OR SEVERITY OF AUTISM SPECTRUM DISORDER

      
Application Number US2024019717
Publication Number 2024/192114
Status In Force
Filing Date 2024-03-13
Publication Date 2024-09-19
Owner FLAASK, LLC (USA)
Inventor
  • Alibek, Ken
  • Farmer, Sean
  • Lefkowitz, Andrew, R.

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/12 - Ketones
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/05 - Phenols
  • A61K 33/30 - ZincCompounds thereof
  • A61K 31/4525 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
  • A61K 31/22 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
  • A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
  • A61P 25/00 - Drugs for disorders of the nervous system

4.

Compositions and methods for diagnosing susceptibility to autism spectrum disorder (ASD), reducing the likelihood of developing ASD, and/or treating ASD

      
Application Number 17828201
Grant Number 12150966
Status In Force
Filing Date 2022-05-31
First Publication Date 2022-09-15
Grant Date 2024-11-26
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew R.
  • Farmer, Sean
  • Alibek, Ken

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/175 - Amino acids
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 36/35 - Caprifoliaceae (Honeysuckle family)
  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
  • A61P 25/00 - Drugs for disorders of the nervous system
  • A61K 9/00 - Medicinal preparations characterised by special physical form

5.

Compositions and Methods for Improving Quality of Life in Patients with Autism Spectrum Disorder

      
Application Number 17299367
Status Pending
Filing Date 2020-01-25
First Publication Date 2022-01-20
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew R.
  • Farmer, Sean
  • Alibek, Ken

Abstract

The present invention provides compositions and methods for treating a subject diagnosed with ASD. In preferred embodiments, the subject compositions comprise tellimagrandin II, glycyrrhizin, monolaurin, selenium, honokiol, a probiotic, and one or more biological amphiphilic molecules, which when administered to a subject, can support immune and/or digestive health, and suppress and/or disable viral pathogenic agents in the body.

IPC Classes  ?

  • A23L 33/16 - Inorganic salts, minerals or trace elements
  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 31/23 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
  • A61K 33/04 - Sulfur, selenium or telluriumCompounds thereof
  • A61K 31/05 - Phenols
  • A61K 35/74 - Bacteria
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/125 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing carbohydrate syrupsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugarsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing sugar alcoholsModifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives containing starch hydrolysates

6.

Compositions and Methods for Cognitive, Immune and Digestive Support in Patients with Autism Spectrum Disorder

      
Application Number 16639632
Status Pending
Filing Date 2018-08-29
First Publication Date 2021-05-06
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew R.
  • Farmer, Sean
  • Alibek, Ken
  • Tskhay, Albina
  • Moldakozhayev, Alibek

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A23L 33/175 - Amino acids
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A61P 25/00 - Drugs for disorders of the nervous system

7.

COMPOSITIONS AND METHODS FOR IMPROVING QUALITY OF LIFE IN PATIENTS WITH AUTISM SPECTRUM DISORDER

      
Application Number US2020015124
Publication Number 2020/154712
Status In Force
Filing Date 2020-01-25
Publication Date 2020-07-30
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew, R.
  • Farmer, Sean
  • Alibek, Ken
  • Tskhay, Albina
  • Moldakozhayev, Alibek

Abstract

The present invention provides compositions and methods for treating a subject diagnosed with ASD. In preferred embodiments, the subject compositions comprise tellimagrandin II, glycyrrhizin, monolaurin, selenium, honokiol, a probiotic, and one or more biological amphiphilic molecules, which when administered to a subject, can support immune and/or digestive health, and suppress and/or disable viral pathogenic agents in the body.

IPC Classes  ?

  • A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
  • A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
  • A61K 31/22 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
  • A61K 33/04 - Sulfur, selenium or telluriumCompounds thereof
  • A61K 31/05 - Phenols
  • A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 25/18 - Antipsychotics, i.e. neurolepticsDrugs for mania or schizophrenia

8.

Compositions and methods for diagnosing susceptibility to autism spectrum disorder (ASD), reducing the likelihood of developing ASD, and/or treating ASD

      
Application Number 16639634
Grant Number 11344585
Status In Force
Filing Date 2018-08-29
First Publication Date 2020-06-11
Grant Date 2022-05-31
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew R.
  • Farmer, Sean
  • Alibek, Ken
  • Tskhay, Albina
  • Moldakozhayev, Alibek

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
  • A23L 33/175 - Amino acids
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A61P 25/00 - Drugs for disorders of the nervous system
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 36/35 - Caprifoliaceae (Honeysuckle family)
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
  • A23L 29/00 - Foods or foodstuffs containing additivesPreparation or treatment thereof
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
  • A61K 9/00 - Medicinal preparations characterised by special physical form

9.

COMPOSITIONS AND METHODS FOR DIAGNOSING SUSCEPTIBILITY TO AUTISM SPECTRUM DISORDER (ASD), REDUCING THE LIKELIHOOD OF DEVELOPING ASD, AND/OR TREATING ASD

      
Application Number US2018048571
Publication Number 2019/046444
Status In Force
Filing Date 2018-08-29
Publication Date 2019-03-07
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew, R.
  • Farmer, Sean
  • Alibek, Ken
  • Tskhay, Albina
  • Moldakozhayev, Alibek

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 31/522 - Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 36/35 - Caprifoliaceae (Honeysuckle family)
  • A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
  • A61P 25/18 - Antipsychotics, i.e. neurolepticsDrugs for mania or schizophrenia
  • A23L 33/17 - Amino acids, peptides or proteins
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics

10.

COMPOSITIONS AND METHODS FOR COGNITIVE, IMMUNE AND DIGESTIVE SUPPORT IN PATIENTS WITH AUTISM SPECTRUM DISORDER

      
Application Number US2018048567
Publication Number 2019/046440
Status In Force
Filing Date 2018-08-29
Publication Date 2019-03-07
Owner FLAASK, LLC (USA)
Inventor
  • Lefkowitz, Andrew, R.
  • Farmer, Sean
  • Alibek, Ken
  • Tskhay, Albina
  • Moldakozhayev, Alibek

Abstract

The present invention provides compositions and methods for improving the quality of life for a subject, particularly a child, diagnosed with autism spectrum disorder (ASD). In preferred embodiments, a supplement composition comprising natural or naturally-derived ingredients is delivered to a subject in the form of a chocolate bar or other candy alongside administration of an antiviral medication. Advantageously, the composition and methods can improve the immune health of the subject, along with other signs and symptoms associated with ASD, infections and other immunocompromising conditions.

IPC Classes  ?

  • A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
  • A61K 36/35 - Caprifoliaceae (Honeysuckle family)
  • A61K 36/63 - Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
  • A61K 36/481 - Astragalus (milkvetch)
  • A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A23L 33/175 - Amino acids
  • A61P 25/18 - Antipsychotics, i.e. neurolepticsDrugs for mania or schizophrenia
  • A61P 31/12 - Antivirals